Premium
Targeted cleavage of HIV‐1 envelope gene by a DNA enzyme and inhibition of HIV‐1 envelope‐CD4 mediated cell fusion
Author(s) -
Dash Bipin C,
Harikrishnan T.A,
Goila Ritu,
Shahi Shweta,
Unwalla Hoshang,
Husain Sajid,
Banerjea Akhil C
Publication year - 1998
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/s0014-5793(98)00799-6
Subject(s) - cleavage (geology) , cell fusion , envelope (radar) , fusion gene , fusion , dna , gene , chemistry , microbiology and biotechnology , enzyme , biology , cell , biochemistry , computer science , paleontology , fracture (geology) , telecommunications , radar , linguistics , philosophy
With the ultimate aim of developing an effective antiviral strategy against HIV‐1, a mono‐DNA enzyme possessing the 10–23 catalytic motif [Santoro and Joyce (1997) Proc. Natl. Acad. Sci. USA 94, 4264–4266] was synthesized against the HIV‐1 envelope gene. We tested the in vitro cleavage efficiency of the 178 bp long truncated HIV‐1 Env transcript by DNA enzyme 6339. Protein independent and Mg 2+ dependent specific cleavage products were obtained. As soon as 5 min after mixing equimolar concentrations of DNA enzyme and substrate RNA, more than 50% cleavage was observed which increased steadily over a period of 4 h. Very little cleavage was obtained at 1 mM MgCl 2 concentration which improved significantly when the concentration of MgCl 2 was increased up to 20 mM. Specific inhibition of cell membrane fusion caused by the interaction of gp160 and CD4 in HeLa cells was observed when the above DNA enzyme was used. Thus, these chemically synthesized DNA enzymes could prove to be very useful for in vivo application.